Review



primary antibodies against cd163  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Novus Biologicals primary antibodies against cd163
    Primary Antibodies Against Cd163, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nbp3+07981/CD163+Antibody+(CL10652)/bio_rxiv__64898__2026__03__01__708642-197-0-7
    Average 94 stars, based on 5 article reviews
    primary antibodies against cd163 - by Bioz Stars, 2026-08
    94/100 stars

    Images



    Similar Products

    primary antibodies against cd163  (Novus Biologicals)
    94
    Novus Biologicals primary antibodies against cd163
    Primary Antibodies Against Cd163, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nbp3+07981/CD163+Antibody+(CL10652)/bio_rxiv__64898__2026__03__01__708642-197-0-7
    Average 94 stars, based on 1 article reviews
    primary antibodies against cd163 - by Bioz Stars, 2026-08
    94/100 stars
    		  Buy from Supplier
    cd163  (Novus Biologicals)
    94
    Novus Biologicals cd163
    Cd163, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nbp3+07981/CD163+Antibody+(CL10652)/pmc12480531-10-0-6
    Average 94 stars, based on 1 article reviews
    cd163 - by Bioz Stars, 2026-08
    94/100 stars
    		  Buy from Supplier
    nbp3 07981  (Novus Biologicals)
    94
    Novus Biologicals nbp3 07981
    Antibodies used for the immunofluorescence study.
    Nbp3 07981, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nbp3+07981/CD163+Antibody+(CL10652)/pmc11414135-21-3-0
    Average 94 stars, based on 1 article reviews
    nbp3 07981 - by Bioz Stars, 2026-08
    94/100 stars
    		  Buy from Supplier
    anti cd163  (Novus Biologicals)
    94
    Novus Biologicals anti cd163
    Antibodies used for the immunofluorescence study.
    Anti Cd163, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nbp3+07981/CD163+Antibody+(CL10652)/10__1158_slash_2767___9764__crc___23___0634-119-16-20
    Average 94 stars, based on 1 article reviews
    anti cd163 - by Bioz Stars, 2026-08
    94/100 stars
    		  Buy from Supplier
    anti cd163 antibodies  (Novus Biologicals)
    94
    Novus Biologicals anti cd163 antibodies
    Fig. 4 AICAR reprogrammed macrophages (MΦ) to assume an anti-inflammatory phenotype. (A and B) Immunofluorescence staining of iNOS and <t>CD163</t> in MΦ and quantitative analysis of the transformation rate of MΦ (n = 5). (C) Quantification of iNOS/CD163 mRNA expression (n = 3). **p < 0.01 and ##p < 0.01 versus the AICAR group. The results are expressed as mean ± SD.
    Anti Cd163 Antibodies, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nbp3+07981/CD163+Antibody+(CL10652)/pm36928127-196-5-10
    Average 94 stars, based on 1 article reviews
    anti cd163 antibodies - by Bioz Stars, 2026-08
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Antibodies used for the immunofluorescence study.

    Journal: Toxicologic Pathology

    Article Title: Biocompatible Solutions: Evaluating the Safety of Repeated Intra-Articular Injections of pMPCylated Liposomes for Knee Osteoarthritis Therapy in Rat Models

    doi: 10.1177/01926233241271400

    Figure Lengend Snippet: Antibodies used for the immunofluorescence study.

    Article Snippet: Novus (CD163) , NBP3-07981 (CD163).

    Techniques: Immunofluorescence, Marker

    Fig. 4 AICAR reprogrammed macrophages (MΦ) to assume an anti-inflammatory phenotype. (A and B) Immunofluorescence staining of iNOS and CD163 in MΦ and quantitative analysis of the transformation rate of MΦ (n = 5). (C) Quantification of iNOS/CD163 mRNA expression (n = 3). **p < 0.01 and ##p < 0.01 versus the AICAR group. The results are expressed as mean ± SD.

    Journal: Biomaterials science

    Article Title: Cellular energy supply for promoting vascular remodeling of small-diameter vascular grafts: a preliminary study of a new strategy for vascular graft development.

    doi: 10.1039/d2bm01338j

    Figure Lengend Snippet: Fig. 4 AICAR reprogrammed macrophages (MΦ) to assume an anti-inflammatory phenotype. (A and B) Immunofluorescence staining of iNOS and CD163 in MΦ and quantitative analysis of the transformation rate of MΦ (n = 5). (C) Quantification of iNOS/CD163 mRNA expression (n = 3). **p < 0.01 and ##p < 0.01 versus the AICAR group. The results are expressed as mean ± SD.

    Article Snippet: Immunofluorescence analysis was performed with anti-CD163 antibodies (1 : 200; Novus) and anti-iNOS antibodies (1 : 500; Novus).

    Techniques: Staining, Transformation Assay, Expressing

    Fig. 9 The infiltration of MΦ phenotypes in the vascular wall during the process of vascular remodeling. (A) Immunofluorescence staining of iNOS-M1 (red) and CD163-M2 (green) in the grafts at 6 and 12 weeks. Nuclei are stained with DAPI (blue). (B) Quantification of the ratio of the per- centage of CD163 : iNOS macrophages infiltrated in the remodeled grafts at various time points after implantation (n = 3). **p < 0.01 and ##p < 0.01. The results are expressed as mean ± SD.

    Journal: Biomaterials science

    Article Title: Cellular energy supply for promoting vascular remodeling of small-diameter vascular grafts: a preliminary study of a new strategy for vascular graft development.

    doi: 10.1039/d2bm01338j

    Figure Lengend Snippet: Fig. 9 The infiltration of MΦ phenotypes in the vascular wall during the process of vascular remodeling. (A) Immunofluorescence staining of iNOS-M1 (red) and CD163-M2 (green) in the grafts at 6 and 12 weeks. Nuclei are stained with DAPI (blue). (B) Quantification of the ratio of the per- centage of CD163 : iNOS macrophages infiltrated in the remodeled grafts at various time points after implantation (n = 3). **p < 0.01 and ##p < 0.01. The results are expressed as mean ± SD.

    Article Snippet: Immunofluorescence analysis was performed with anti-CD163 antibodies (1 : 200; Novus) and anti-iNOS antibodies (1 : 500; Novus).

    Techniques: Staining